{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05581576",
            "orgStudyIdInfo": {
                "id": "PRO00033508"
            },
            "organization": {
                "fullName": "The Methodist Hospital Research Institute",
                "class": "OTHER"
            },
            "briefTitle": "Pitolisant in Refractory Restless Legs Syndrome",
            "officialTitle": "Open Label Assessment of Pitolisant (Wakix) as Adjunct Therapy for Patients With Refractory Restless Legs Syndrome",
            "therapeuticArea": [
                "Rare Diseases"
            ],
            "study": "pitolisant-in-refractory-restless-legs-syndrome"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-09-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-05-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2023-05-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-09-01",
            "studyFirstSubmitQcDate": "2022-10-13",
            "studyFirstPostDateStruct": {
                "date": "2022-10-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-10-13",
            "lastUpdatePostDateStruct": {
                "date": "2022-10-14",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "William Ondo, MD",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "The Methodist Hospital Research Institute"
            },
            "leadSponsor": {
                "name": "William Ondo, MD",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Harmony Biosciences, LLC",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "This is an open-label trial in Restless Legs Syndrome (RLS) patients inadequately treated with standard therapy, defined by an IRLS score greater than 15. Investigators hypothesize that the study drug, Pitolisant (Wakix), may improve RLS symptoms.",
            "detailedDescription": "This is an open-label trial in RLS patients who have been inadequately treated with standard therapies, defined by an IRLS \\> 15. This trial consists of four study center visits (weeks 0, 4, 8, and 16) and four telephone visits (weeks 1, 3, 11, and a post safety phone call at week 17).\n\nSubjects will titrate pitolisant for three weeks, starting with a dose of 8.9 mg at week 1, then increase to 17.8 mg at week 2, and a final increase to maximum dosage of 35.6 mg at week 3. If subjects are unable to tolerate the highest dose, they may reduce their dose to 17.8 mg. Titration of the drug will be monitored via telephone visits. During weeks 0-8, subjects will continue to take their current RLS medications. From week 8-16, subjects may either reduce or stop their other RLS medications as mutually agreed upon with investigator.\n\nSeveral questionnaire assessments will be conducted throughout the study to monitor the subjects. Subjects will complete the International RLS Rating Scale (IRLS), Restless Legs Syndrome - 6 Scale (RLS-6), RLS Quality of Life Questionnaire (RLSQoL), Fatigue Severity Scale (FSS), Hamilton Depression Scale (HDS), Montreal Cognitive Assessment (MoCA), Epworth Sleepiness Scale (ESS), Clinical Global Impressions (CGI), and Clinical Global Impressions-Change (CGI-C)."
        },
        "conditionsModule": {
            "conditions": [
                "Restless Legs Syndrome"
            ],
            "keywords": [
                "Refractory"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 18,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Pitolisant (Wakix)",
                    "type": "EXPERIMENTAL",
                    "description": "Pitolisant will be titrated weekly until maximum dosage of 35.6 mg. Titration is dependent on subjects response.",
                    "interventionNames": [
                        "Drug: Pitolisant"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Pitolisant",
                    "description": "Pitolisant initial dose 8.9 mg, titrated depending on symptomatic response.",
                    "armGroupLabels": [
                        "Pitolisant (Wakix)"
                    ],
                    "otherNames": [
                        "Wakix"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "International RLS Rating Scale (IRLS)",
                    "description": "This is a subjective scale to measure the severity of RLS within the past week.",
                    "timeFrame": "At week 8"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "The Restless Legs Syndrome - 6 Scale (RLS-6)",
                    "description": "This scale measures the severity of daytime versus nighttime RLS symptoms.",
                    "timeFrame": "Baseline, 4 weeks, 8 weeks, and 16 weeks"
                },
                {
                    "measure": "Restless Legs Syndrome Quality of Life Questionnaire (RLSQoL)",
                    "description": "This scale assess the quality of life in RLS patients.",
                    "timeFrame": "Baseline, 4 weeks, 8 weeks, and 16 weeks"
                },
                {
                    "measure": "Fatigue Severity Scale (FSS)",
                    "description": "This scale evaluates the impact of fatigue patients are experiencing.",
                    "timeFrame": "Baseline, 4 weeks, 8 weeks, and 16 weeks"
                },
                {
                    "measure": "Hamilton Depression Scale (HDS)",
                    "description": "This scale assess symptoms of depression.",
                    "timeFrame": "Baseline, 4 weeks, 8 weeks, and 16 weeks"
                },
                {
                    "measure": "Montreal Cognitive Assessment (MoCA)",
                    "description": "This assessment detects mild cognitive impairment.",
                    "timeFrame": "Baseline, 4 weeks, 8 weeks, and 16 weeks"
                },
                {
                    "measure": "Epworth Sleepiness Scale (ESS)",
                    "description": "This is a subjective scale that measures a patient's sleepiness.",
                    "timeFrame": "Baseline, 4 weeks, 8 weeks, and 16 weeks"
                },
                {
                    "measure": "Clinical Global Impressions - Change",
                    "description": "This scale assess how much a patients illness has improved or worsened when compared to a baseline state from the beginning of the intervention.",
                    "timeFrame": "1 week, 2 weeks, 4 weeks, 8 weeks, 11 weeks, 16 weeks, and 17 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* RLS diagnosed by standard criteria with an IRLS \\> 15 while taking at least 1 RLS medication\n* Stable RLS medications for at least 2 weeks prior to study entry\n\nExclusion Criteria:\n\n* MoCA \\< 24\n* Concurrent untreated sleep disorders, not felt to be stable\n* Subjects with any significant, unstable cardiovascular, liver, lung, renal, psychiatric, or neurological diseases (not including RLS)\n* Intravenous iron within 4 weeks of study entry\n* Breast feeding or pregnancy determined by urine pregnancy test in subjects where pregnancy is possible (pre-menopausal, sexually active women)\n* Subjects with previous allergic reaction or lack of tolerability to Pitolisant",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "21 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "William Ondo, MD",
                    "role": "CONTACT",
                    "phone": "7133638184",
                    "email": "wondo@houstonmethodist.org"
                },
                {
                    "name": "Shivani M Desai, BS",
                    "role": "CONTACT",
                    "phone": "7133638390",
                    "email": "sdesai5@houstonmethodist.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "William Ondo, MD",
                    "affiliation": "The Methodist Hospital Research Institute",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Houston Methodist Hospital",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Shivani M Desai, BS",
                            "role": "CONTACT",
                            "phone": "713-363-8390",
                            "email": "sdesai5@houstonmethodist.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011595",
                    "term": "Psychomotor Agitation"
                },
                {
                    "id": "D000012148",
                    "term": "Restless Legs Syndrome"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000020820",
                    "term": "Dyskinesias"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000011596",
                    "term": "Psychomotor Disorders"
                },
                {
                    "id": "D000019954",
                    "term": "Neurobehavioral Manifestations"
                },
                {
                    "id": "D000096762",
                    "term": "Aberrant Motor Behavior in Dementia"
                },
                {
                    "id": "D000001526",
                    "term": "Behavioral Symptoms"
                },
                {
                    "id": "D000020919",
                    "term": "Sleep Disorders, Intrinsic"
                },
                {
                    "id": "D000020920",
                    "term": "Dyssomnias"
                },
                {
                    "id": "D000012893",
                    "term": "Sleep Wake Disorders"
                },
                {
                    "id": "D000020447",
                    "term": "Parasomnias"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14452",
                    "name": "Psychomotor Agitation",
                    "asFound": "Restless",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14984",
                    "name": "Restless Legs Syndrome",
                    "asFound": "Restless Legs Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22574",
                    "name": "Dyskinesias",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M14453",
                    "name": "Psychomotor Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21826",
                    "name": "Neurobehavioral Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M6904",
                    "name": "Dementia",
                    "relevance": "LOW"
                },
                {
                    "id": "M3259",
                    "name": "Aberrant Motor Behavior in Dementia",
                    "relevance": "LOW"
                },
                {
                    "id": "M4818",
                    "name": "Behavioral Symptoms",
                    "relevance": "LOW"
                },
                {
                    "id": "M22242",
                    "name": "Parasomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M22654",
                    "name": "Sleep Disorders, Intrinsic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22655",
                    "name": "Dyssomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M15696",
                    "name": "Sleep Wake Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                }
            ]
        }
    },
    "hasResults": false
}